Leadership Change

Resalis Therapeutics poaches a top clinical leader from Novo Nordisk to steer its novel RNA-based obesity drug, RES-010, through clinical trials.

By appointing two legendary specialists, XGEN isn't just shuffling its board. It's aiming to legitimize whole genome sequencing for all IVF patients.

A Singaporean AI firm hires a trio of veterans from a $1.5B exit to lead a bold global expansion, betting on a unified platform to fix a fragmented market.

With a seasoned CEO and a tech transformation guru joining its board, San Diego's Curebound signals a strategic shift to fast-track cancer cures.

MatrixCare goes independent via a Frazier Healthcare acquisition, appointing a new CEO to accelerate innovation in the critical post-acute care tech space.

Evers & Sons is launching an engineering division to fix a long-standing industry disconnect. Can their 'constructability first' model redefine project delivery?

Applied Aerospace & Defense appoints Elizabeth Robertson, a former NASA engineer, to drive growth, signaling a strategic push into mission-critical programs.

Hannover Re US taps veteran Sean Conrad to lead its data analytics and pricing. This isn't just a promotion; it's a strategic bet on the future of life insurance.

Medical laser giant Fotona creates a CPO role, hiring a top exec from Intuitive Surgical. The move signals a major strategic shift toward next-gen innovation.

With a new CEO known for successful private equity exits, video security firm IQSIGHT is positioning to turn its Bosch engineering legacy into market dominance.

ElevateBio's new COO, Steven Falcone, is a strategic weapon against the crushing cost of advanced therapy manufacturing. This isn't just a hire; it's a war on the price of miracles.

A top general joins a defense AI firm, promising to revolutionize military readiness. But does the well-trod path from battlefield to boardroom accelerate innovation or just grease the wheels of the military-industrial complex?

With a long-serving CFO out and ambitious Brazilian growth plans on the line, Serabi Gold bets on an interim leader to navigate a crucial transition.

With a key hire in Australia, Health-ISAC is signaling a major escalation in the fight to secure APAC's vulnerable healthcare sector from cyber threats.

Two years post-acquisition, the bank appoints a veteran bank-builder and a serial entrepreneur to its board, signaling a strategic shift in a competitive market.

With veteran local leader Megan Rood at the helm, Colorado Urology is poised to expand its integrated care model, backed by a major national partnership.

With AI reshaping cyber threats, Skyhigh Security appoints a new COO with a proven record of scaling tech giants. Can he turn market momentum into dominance?

The departure of a key board member from Tulikivi is more than a personnel change; it is a window into the diverging strategies of Finnish industry.

As it launches a pivotal trial for its MYC inhibitor, Persevere Therapeutics adds a seasoned CEO to its board, signaling a sharp focus on funding and strategy.

The firm taps Chris Karkenny, a CEO known for scaling healthcare firms via M&A, signaling a strategic shift to professionalize and accelerate its expansion.